DJ Novavax Inc. Stock Underperforms Monday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Novavax Inc. $(NVAX)$ slid 1.43% to $8.93 Monday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.32% to 49,686.12 and the NASDAQ Composite Index falling 0.51% to 26,090.73.
This was the stock's second consecutive day of losses.
Novavax Inc. closed 25.40% short of its 52-week high of $11.97, which the company reached on February 26th.
The stock underperformed when compared to some of its competitors Monday, as Johnson & Johnson $(JNJ)$ rose 0.97% to $228.92, Pfizer Inc. $(PFE)$ remained unchanged, and Merck & Co. Inc. $(MRK)$ rose 1.06% to $112.56.
Trading volume (4.8 M) eclipsed its 50-day average volume of 4.4 M.
Data source: Dow Jones Market Data, FactSet. Data compiled May 18, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
May 18, 2026 17:27 ET (21:27 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments